Bio-Rad Laboratories Inc Asset Resilience Ratio
Bio-Rad Laboratories Inc asset resilience ratio. Bio-Rad Laboratories Inc (BIO) has an Asset Resilience Ratio of 10.74% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Bio-Rad Laboratories Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Bio-Rad Laboratories Inc (2003–2025)
Asset resilience ratio of Bio-Rad Laboratories Inc from 2003 to 2025. This chart shows how Bio-Rad Laboratories Inc's Asset Resilience Ratio has changed over time. Read Bio-Rad Laboratories Inc (BIO) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Bio-Rad Laboratories Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BIO asset base.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.10 Billion | 10.74% |
| Total Liquid Assets | $1.10 Billion | 10.74% |
Asset Resilience Insights
- Moderate Liquidity: Bio-Rad Laboratories Inc has 10.74% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Bio-Rad Laboratories Inc Industry Peers by Asset Resilience Ratio
Compare Bio-Rad Laboratories Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Bio-Rad Laboratories Inc Asset Resilience Ratio by Year (2003–2025)
Bio-Rad Laboratories Inc asset resilience ratio by year from 2003 to 2025. The table below shows the annual Asset Resilience Ratio data for Bio-Rad Laboratories Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 14.57% | $1.54 Billion | $10.58 Billion | -3.21pp |
| 2024-12-31 | 17.78% | $1.66 Billion | $9.36 Billion | +4.71pp |
| 2023-12-31 | 13.07% | $1.61 Billion | $12.30 Billion | -0.20pp |
| 2022-12-31 | 13.26% | $1.79 Billion | $13.50 Billion | +8.38pp |
| 2021-12-31 | 4.89% | $869.92 Million | $17.80 Billion | -2.75pp |
| 2020-12-31 | 7.64% | $991.12 Million | $12.97 Billion | -6.28pp |
| 2019-12-31 | 13.92% | $1.11 Billion | $8.01 Billion | -1.14pp |
| 2018-12-31 | 15.06% | $844.80 Million | $5.61 Billion | -2.61pp |
| 2017-12-31 | 17.67% | $754.98 Million | $4.27 Billion | -4.13pp |
| 2016-12-31 | 21.80% | $839.44 Million | $3.85 Billion | +12.94pp |
| 2015-12-31 | 8.86% | $328.72 Million | $3.71 Billion | +0.35pp |
| 2014-12-31 | 8.51% | $284.38 Million | $3.34 Billion | +0.33pp |
| 2013-12-31 | 8.18% | $277.37 Million | $3.39 Billion | -5.11pp |
| 2012-12-31 | 13.29% | $457.69 Million | $3.44 Billion | +5.58pp |
| 2011-12-31 | 7.71% | $238.88 Million | $3.10 Billion | +3.84pp |
| 2010-12-31 | 3.87% | $118.64 Million | $3.06 Billion | +0.13pp |
| 2009-12-31 | 3.74% | $94.88 Million | $2.54 Billion | +1.83pp |
| 2008-12-31 | 1.91% | $38.95 Million | $2.04 Billion | -1.23pp |
| 2007-12-31 | 3.14% | $61.98 Million | $1.97 Billion | -13.43pp |
| 2006-12-31 | 16.57% | $264.47 Million | $1.60 Billion | +8.41pp |
| 2005-12-31 | 8.16% | $116.34 Million | $1.43 Billion | -3.94pp |
| 2004-12-31 | 12.10% | $165.90 Million | $1.37 Billion | +3.71pp |
| 2003-12-31 | 8.39% | $83.25 Million | $992.60 Million | -- |
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, pu… Read more